Cargando…
Placing the results of the SOLIDARITY trial with regards to remdesivir in perspective
Remdesivir, a repurposed antiviral, was first accorded approval by the US Food Drug Administration (FDA) for the treatment of COVID-19 which necessitates hospitalization. However, the interim data of SOLIDARITY trial revealed no benefits with remdesivir for COVID-19 patients which led immediate deba...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272424/ https://www.ncbi.nlm.nih.gov/pubmed/34259182 http://dx.doi.org/10.4103/lungindia.lungindia_883_20 |